Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India

Authors: Khalid Hamid Changal, Ab Hameed Raina, Adnan Raina, Manzoor Raina, Rehana Bashir, Muzamil Latief, Tanveer Mir, Qayum Hamid Changal

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Secondary dengue causes more severe disease than the primary. Early on, it is important to differentiate the two. We tried to find important clinical and laboratory differences between the two for the purpose of early differentiation.

Methods

One hundred fourteen patients confirmed on reverse transcriptase-polymerase chain reaction (RT PCR) were studied. On day 2 of illness IgM and IgG indices were studied for calculation of IgG/IgM ratio. A one-step immunochromatographic assay was used for classification of patients into primary and secondary dengue. Patient characteristics were also studied.

Results

Dengue serotype 1 was the most common found in 60.5% patients. 66.7% (76 patients) had secondary dengue. Secondary dengue cases had a higher mean temperature (101.56 ± 1.55 vs. 100.79 ± 1.25,°F, p 0.015), lower platelet counts (50.51 ± 38.91 vs. 100.45 ± 38.66, x 103/micl, p <0.0001) and a significantly higher percentage of Dengue hemorrhagic fever/Dengue shock syndrome (38.2% vs. 2.6%, p <0.0001). In early phase of dengue NS1 and PCR were found to be better tests for diagnosis and later IgM is better. The IgG/IgM ratio of ≥ 1.10 had a sensitivity of 100%, specificity of 97.4% and accuracy of 67.5% in differentiating secondary from primary dengue.

Conclusion

Early on in the clinical course, IgG/ IgM ratio can play an important role to differentiate the two. We found the ratio of ≥ 1.10 to be the best cut off for the same.
Literature
3.
go back to reference WHO. Dengue: guidelines for diagnosis, treatment, prevention, and control in sub-Saharan Africa and 13 countries in South America. Geneva: World Health Organization; 2009. WHO. Dengue: guidelines for diagnosis, treatment, prevention, and control in sub-Saharan Africa and 13 countries in South America. Geneva: World Health Organization; 2009.
6.
go back to reference Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38:172–80.PubMed Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38:172–80.PubMed
8.
go back to reference World Health Organization. Dengue haemorrhagic fever: diagnosis; treatment and control. Geneva: World Health Organization; 1997. World Health Organization. Dengue haemorrhagic fever: diagnosis; treatment and control. Geneva: World Health Organization; 1997.
9.
go back to reference Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Kneen R, Cuzzubho A, Devine P. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg. 1999;60:693–8.PubMed Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Kneen R, Cuzzubho A, Devine P. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg. 1999;60:693–8.PubMed
10.
go back to reference De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis. 2004;8:390–8.CrossRefPubMed De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis. 2004;8:390–8.CrossRefPubMed
11.
go back to reference De Souza VA, Fernandes S, Araujo ES, Tateno AF, Oliveira OM, Oliveira RR, Pannuti CS. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J Clin Microbiol. 2004;42:1782–4.CrossRefPubMedPubMedCentral De Souza VA, Fernandes S, Araujo ES, Tateno AF, Oliveira OM, Oliveira RR, Pannuti CS. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J Clin Microbiol. 2004;42:1782–4.CrossRefPubMedPubMedCentral
12.
go back to reference Innis BL, Nisalak S, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, et al. An enzyme linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co circulate. Am J Trop Med Hyg. 1989;40:418–27.PubMed Innis BL, Nisalak S, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, et al. An enzyme linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co circulate. Am J Trop Med Hyg. 1989;40:418–27.PubMed
13.
go back to reference Martinez E, Guzman MG, Valdes M, Soler M, Kouri G. Dengue and dengue hemorrhagic fever in infants with a primary infection. Rev Cubana Med Trop. 1993;45:97–101.PubMed Martinez E, Guzman MG, Valdes M, Soler M, Kouri G. Dengue and dengue hemorrhagic fever in infants with a primary infection. Rev Cubana Med Trop. 1993;45:97–101.PubMed
14.
go back to reference Pei YS, Li KC, Shu FC, Yi YY, Ling C, Li JC, et al. Comparison of capture imunoglobulin M (IgM) and IgG enzym-linked immunoabsorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. J Clin Immunol. 2003;10:622–30. Pei YS, Li KC, Shu FC, Yi YY, Ling C, Li JC, et al. Comparison of capture imunoglobulin M (IgM) and IgG enzym-linked immunoabsorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. J Clin Immunol. 2003;10:622–30.
15.
16.
go back to reference Falconar AKI, de Plata E, Romero-Vivas CME. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin Vaccine Immunol. 2006;13:1044–51. doi:10.1128/CVI.00105-06.CrossRefPubMedPubMedCentral Falconar AKI, de Plata E, Romero-Vivas CME. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin Vaccine Immunol. 2006;13:1044–51. doi:10.​1128/​CVI.​00105-06.CrossRefPubMedPubMedCentral
19.
go back to reference SA-NGASANG A, ANANTAPREECHA S, A-NUEGOONPIPAT A, et al. Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol Infect. 2006;134(4):820–5. doi:10.1017/S0950268805005753.CrossRefPubMed SA-NGASANG A, ANANTAPREECHA S, A-NUEGOONPIPAT A, et al. Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol Infect. 2006;134(4):820–5. doi:10.​1017/​S095026880500575​3.CrossRefPubMed
20.
go back to reference Stephenson JR. Understanding dengue pathogenesis: implication for vaccine design. Bull World Health Organ. 2005;83:308–14.PubMedPubMedCentral Stephenson JR. Understanding dengue pathogenesis: implication for vaccine design. Bull World Health Organ. 2005;83:308–14.PubMedPubMedCentral
21.
go back to reference Matlani M, Chakravarti A. Changing trends of dengue disease: a brief report from a tertiary care hospital in New Delhi. Braz J Infect Dis. 2011;15:184–5.CrossRefPubMed Matlani M, Chakravarti A. Changing trends of dengue disease: a brief report from a tertiary care hospital in New Delhi. Braz J Infect Dis. 2011;15:184–5.CrossRefPubMed
22.
go back to reference Prakash O, Singh DD, Mishra G, et al. Observation on dengue cases from a virus diagnostic laboratory of a tertiary care hospital in north India. Indian J Med Res. 2015;142(Supplement):7–11. doi:10.4103/0971-5916.176596. Prakash O, Singh DD, Mishra G, et al. Observation on dengue cases from a virus diagnostic laboratory of a tertiary care hospital in north India. Indian J Med Res. 2015;142(Supplement):7–11. doi:10.​4103/​0971-5916.​176596.
26.
go back to reference Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997;176:322–30.CrossRefPubMed Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997;176:322–30.CrossRefPubMed
27.
go back to reference Chanama S, Anantapreecha S, A-nuegoonpipat A, et al. Analysis of specific IgM response in secondary dengue infection: level and positive rates in comparison with primary infection. J Clin Virol. 2004;31:185–9.CrossRefPubMed Chanama S, Anantapreecha S, A-nuegoonpipat A, et al. Analysis of specific IgM response in secondary dengue infection: level and positive rates in comparison with primary infection. J Clin Virol. 2004;31:185–9.CrossRefPubMed
28.
go back to reference Martínez E, Guzmán MG, Valdés M, et al. Dengue fever and hemorrhagic dengue in infants with a primary infection. Rev Cubana Med Trop. 1993;45(2):97–101.PubMed Martínez E, Guzmán MG, Valdés M, et al. Dengue fever and hemorrhagic dengue in infants with a primary infection. Rev Cubana Med Trop. 1993;45(2):97–101.PubMed
29.
go back to reference Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn S, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003;68:191.PubMed Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn S, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003;68:191.PubMed
30.
go back to reference Gibbons RV, Kalayanarooj S, Jarman RG, Nisalak A, Vaughn DW, et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg. 2007;77:910–3.PubMed Gibbons RV, Kalayanarooj S, Jarman RG, Nisalak A, Vaughn DW, et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg. 2007;77:910–3.PubMed
Metadata
Title
Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India
Authors
Khalid Hamid Changal
Ab Hameed Raina
Adnan Raina
Manzoor Raina
Rehana Bashir
Muzamil Latief
Tanveer Mir
Qayum Hamid Changal
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2053-6

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.